CAREDX, INC. Share Repurchase Authorization
CAREDX, INC. (CDNA) had Share Repurchase Authorization of $50.00 million as of 2022-12-03, per its 10-K filed 2025-02-28.
Financial Statements › Notes › Equity
srt:StockRepurchaseProgramAuthorizedAmount1 · last filed 2025-02-28
- 2022-12-03: Stock Repurchase Program Authorized Amount1 $50.00M.
| Period end | Stock Repurchase Program Authorized Amount1 |
|---|---|
| 2022-12-03 | $50.00M 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |